tirzepatide westshore — Dual GIP/GLP-1 Treatment Tirzepatide Weight Loss Injections &
Description
In 2022, it received approval from the United States Food and Drug Administration (FDA) as a treatment of T2D under the brand name Mounjaro [6]
En tratamientos de control del peso, Mounjaro es una opcin teraputica de ltima generacin
These benefits may extend to individuals with MASH, however there are currently no retatrutide trials planned in populations with MASLD/MASH
In SURMOUNT-1, the 5mg group averaged 16% body weight reduction
However, the amount of BAT in adults is minimal
